Forum LABO Paris 2027

Why is Benchtop NMR the new analytical standard for the Laboratory ?

Mar 24, 2027 — 10:00 am - 11:00 AM
Atelier Exposant - Salle 1

Description

Fifteen years ago, Magritek introduced the first benchtop NMR spectrometer to the market, opening new possibilities for nuclear magnetic resonance spectroscopy beyond traditional high-field NMR facilities. By making NMR more accessible, compact, and convenient to use, this technology has enabled a broad range of applications across research, education, and industry. Benchtop NMR has rapidly evolved from a teaching tool into a versatile analytical platform, providing valuable structural and quantitative information on a remarkably diverse range of samples. Its ease of use, minimal sample preparation requirements, and potential for rapid, non-destructive analysis have made it an attractive solution for applications ranging from chemical characterization and reaction monitoring to quality control and process monitoring. This presentation will review some of the most successful and impactful applications developed over the past fifteen years, with particular emphasis on innovations that reduce or eliminate the need for deuterated solvents and cryogens. These advances further simplify NMR analysis, reduce operating costs, and broaden the range of settings in which the technology can be deployed. Finally, the presentation will explore emerging opportunities and future directions, highlighting how advances in instrumentation, data analysis, and application development are expected to further expand the role of benchtop NMR in research, industrial laboratories, and process analytical technology.

Speakers

In partnership with

Suggested sessions

Agora
Mar 23, 2027
10:00 AM11:30 AM
Innovation and scientific valorization

Opening conference - The laboratory in motion: how can we improve efficiency, strengthen reliability, and advance sustainable practices?

Description
Tight budgets, regulatory requirements, automation and artificial intelligence, resource optimization, environmental and climate imperatives... Laboratories must reconcile growing challenges while supporting their teams and preparing for the transformations of the coming years. • How can they innovate while keeping costs under control? • How can they automate while retaining control over operations? • How can they strengthen the reliability of results and reduce their environmental footprint with a constant budget? • How can they develop and retain the necessary skills without increasing pressure on teams? • Though these demands may seem contradictory, they can become drivers of progress. Drawing on feedback from laboratories that have successfully carried out transformations, this opening conference explores the technological, organizational, and human choices that are proving effective. Artificial intelligence, precision or miniaturized instrumentation, new sustainable practices: what concrete benefits can they deliver, what conditions are needed for success, and what impact will they have on professions and roles? Looking at yesterday’s choices to shed light on today’s decisions: which strategic shifts have paid off, which practices can be adapted to other organizations, and which directions should be taken as early as 2027?
Agora
Mar 23, 2027
11:30 AM12:00 PM
Innovation and scientific valorization

Innovation Awards Ceremony

Description
The Forum LABO 2027 Awards celebrate and recognize projects, laboratories, teams, and individuals who stand out for their scientific or technical excellence, a major innovation, or a significant impact on their region, their sector, or the scientific community. These awards also encourage collaboration, equality, and diversity in the scientific world.
Atelier Exposant - Salle 1
Mar 23, 2027
1:15 PM1:45 PM
Industry & materials

Maintenance et contrôles réglementaires pour les équipements de laboratoire

Speakers:
Jérémie LECOLLINETLABO AND CODirecteur commercial
Description
Laboratories are required to comply with an increasing number of regulatory obligations, without necessarily being required to maintain their equipment. However, compliance does not mean performance. This workshop begins with maintenance and its concrete benefits: fewer breakdowns, longer-lasting equipment, and controlled costs. It then presents regulatory inspections: their role, their limits, and the equipment concerned. Finally, it addresses metrology, which is essential to ensure measurement accuracy and cannot be replaced by either maintenance or regulatory inspections. Participants will leave knowing how to combine these three approaches to secure the use of their equipment and the reliability of their results.
Labo and Co
Atelier Exposant - Salle 2
Mar 23, 2027
2:00 PM3:00 PM
Transition & regulationIndustry & materialsInnovation and scientific valorization

La technologie TriMax des colonnes RMX améliore les performances de vos analyses GC

Speakers:
THIERRY LAURENTRESTEK FRANCEIngénieur technico commercial
Description
Laboratories today face increasingly demanding requirements: lower detection limits, more complex matrices, regulatory constraints, and a growing need for productivity. Discover how the new Restek RMX columns, featuring the revolutionary TriMax deactivation technology, help improve sensitivity, the quality of your results, and column lifetime for GC-MS and GC-MS/MS methods. Through concrete examples from environmental analyses involving compounds that are difficult to identify (SVOC, PAH, PCB), we will see how to obtain more reliable results while improving method robustness and extending column lifetime. Key takeaways: • Improved inertness of RMX columns thanks to TriMax technology → increased sensitivity for difficult compounds (SVOC, PAH, PCB) • Extended column lifetime → fewer replacements, less maintenance time • Greater robustness → lower detection limits, easier regulatory compliance
Restek France
Salle Marie Curie
Mar 23, 2027
4:00 PM4:45 PM
Industry & materials

ESA

Description
Space and space biology
Atelier Exposant - Salle 2
Mar 23, 2027
4:00 PM5:00 PM
Industry & materialsInnovation and scientific valorization

Evolving Regulatory Requirements and the European Pharmacopoeia: Supporting GLP/GMP Laboratories in Their Analytical Practices – LAB EXPERT

Description
Changes to the European Pharmacopoeia and regulatory landscape are encouraging GLP/GMP laboratories to adopt more modern, sustainable methods while continuing to demonstrate assay performance, data integrity and traceability. In this presentation, Molecular Devices will explore how SpectraMax® microplate readers, cellular imaging technologies and SoftMax® Pro software can support laboratories as methods and regulatory expectations evolve. Through practical examples, we will look at four key areas: Pyrogen and endotoxin detection Discover how SpectraMax® readers and SoftMax® Pro can support kinetic chromogenic and turbidimetric LAL assays, recombinant Factor C (rFC) assays and the Monocyte Activation Test (MAT), helping laboratories transition towards modern and animal-free testing approaches. Cellular imaging in regulated laboratories See how combining quantitative results with visual assessment of cell populations can provide greater insight into assay performance, with applications including potency assays and batch-release testing. We will also consider how imaging can be integrated into GMP/GLP workflows while supporting data integrity and traceability. Demonstrating equivalence during method transfer Moving an established method between instruments or laboratories requires confidence that results remain comparable. We will explore an approach to evaluating and documenting equivalence within predefined, scientifically justified limits. Statistical evaluation of regression models Learn how statistical tools, including analysis of variance (ANOVA), can help assess model suitability and dose-dependent responses, and how these evaluations can be incorporated into routine analysis using SoftMax® Pro software. Attendees will gain practical insight into how modern detection, imaging and analysis technologies can help laboratories respond to evolving European Pharmacopoeia expectations while maintaining reliable results, robust methods and traceable data.
MOLECULAR DEVICES